Cargando…
Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells
Diosmetin (Dio) is a major active component of flavonoid compounds. A previous study demonstrated that Dio exhibited anticancer activity and induced apoptosis in HepG2 human hepatoma cells via cytochrome P450, family 1-catalyzed metabolism. The present study observed that cell proliferation of HepG2...
Autores principales: | LIU, BIN, SHI, YUFENG, PENG, WENDING, ZHANG, QINGYU, LIU, JIE, CHEN, NIANPING, ZHU, RUNZHI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918616/ https://www.ncbi.nlm.nih.gov/pubmed/27176768 http://dx.doi.org/10.3892/mmr.2016.5258 |
Ejemplares similares
-
Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cells
por: Qiao, Jie, et al.
Publicado: (2016) -
Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells
por: Liu, Jie, et al.
Publicado: (2016) -
Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells
por: Wu, Shixing, et al.
Publicado: (2013) -
Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells
por: Chen, Chuan, et al.
Publicado: (2020) -
In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells
por: Lu, Xun, et al.
Publicado: (2011)